Multiplelines of evidence suggest that PPARs, especially PPARγ, are known to be expressed or overexpressed inseveral cancers such as epithelial tumor cells, renal cell carcinoma cells,myeloid and lymphoid malignancies, and multiple myeloma cells [33–37]. Here, PPARG is linked to plasma cell myeloma.